Mcp1 Promotes Macrophage-Dependent Cyst Expansion in Autosomal Dominant Polycystic Kidney Disease

Marcelo F Cassini1, Vijayakumar R Kakade1, Elizabeth Kurtz1

  • 1Section of Nephrology, Department of Medicine.

Abstract

Insights

Monocyte chemoattractant protein-1 (Mcp1) drives macrophage accumulation and cyst growth in polycystic kidney disease (PKD). Reducing Mcp1 slows cyst progression and improves kidney function in a mouse model.

Area of Science:

  • Nephrology
  • Immunology
  • Genetics

Background:

  • Autosomal dominant polycystic kidney disease (ADPKD) is characterized by excessive macrophage accumulation around kidney cysts, promoting their growth.
  • Monocyte chemoattractant protein-1 (Mcp1) is implicated as a key signaling molecule in macrophage-mediated cystogenesis in ADPKD.

Purpose of the Study:

  • To elucidate the specific role of Mcp1 and macrophages in driving cyst development and progression in ADPKD.
  • To investigate the therapeutic potential of targeting the Mcp1 pathway in ADPKD.

Main Methods:

  • Utilized inducible knockout mouse models: Pkd1 single knockout and Pkd1/Mcp1 double knockout in renal tubules.
  • Quantified Mcp1 RNA expression and assessed macrophage infiltration and activation states.
  • Evaluated cyst morphology, tubular cell injury, proliferation rates, and renal function.

Main Results:

  • Mcp1 upregulation preceded macrophage infiltration in Pkd1 knockout mice.
  • Macrophages exhibited dual roles: initial proinflammatory effects causing injury, followed by an alternative activation phenotype promoting proliferation-dependent cyst growth.
  • Mcp1 knockout significantly reduced macrophage infiltration, attenuated tubular injury, slowed cyst growth, and improved renal function, partially replicated by Ccr2 inhibition.

Conclusions:

  • Mcp1 is a critical mediator of macrophage recruitment and subsequent cystogenesis in a mouse model of ADPKD.
  • Targeting Mcp1 effectively mitigates cyst growth through both proliferation-independent and -dependent mechanisms, offering a potential therapeutic strategy.

Related Concept Videos

Incomplete Dominance01:43

Incomplete Dominance

Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
30.0K
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
739
The Ratio of X Chromosome to Autosomes02:45

The Ratio of X Chromosome to Autosomes

In most organisms, sex is determined by the ratio of X and Y chromosomes. However, in some organisms, such as Drosophila and C.elegans, sex is determined by the ratio of the number of X chromosomes to the number of sets of autosomes. The Y chromosome in Drosophila is active but does not determine sex. It contains genes responsible for the production of sperms in adult flies.  
Normal male Drosophila has a ratio of one X chromosome to two sets of autosomes. In contrast, normal female...
9.8K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
664
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
478
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
397